T

T Man Pharmaceutical PCL
SET:TMAN

Watchlist Manager
T Man Pharmaceutical PCL
SET:TMAN
Watchlist
Price: 10.4 THB 0.97%
Market Cap: 4.2B THB

Profitability Summary

T Man Pharmaceutical PCL's profitability score is 48/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

48/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

48/100
Profitability
Score
48/100
Profitability
Score

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
T Man Pharmaceutical PCL

Revenue
2.2B THB
Cost of Revenue
-1.1B THB
Gross Profit
1.1B THB
Operating Expenses
-1.1B THB
Operating Income
0 THB
Other Expenses
0 THB
Net Income
0 THB

Margins Comparison
T Man Pharmaceutical PCL Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
TH
T Man Pharmaceutical PCL
SET:TMAN
4.2B THB
50%
0%
0%
UK
Eight Capital Partners PLC
F:ECS
633.6T EUR N/A N/A N/A
US
GE Vernova LLC
NYSE:GEV
157.3B USD
20%
4%
5%
US
China Industrial Group Inc
OTC:CIND
121B USD
16%
10%
9%
MY
Malton Bhd
KLSE:MALTON
218m MYR
0%
12%
2%
NL
Nepi Rockcastle NV
JSE:NRP
87B Zac
66%
62%
63%
US
Coupang Inc
F:788
45.4B EUR
30%
2%
1%
US
CoreWeave Inc
NASDAQ:CRWV
46.7B USD
74%
8%
-39%
CH
Galderma Group AG
SIX:GALD
35.4B CHF
69%
16%
8%
US
Symbotic Inc
NASDAQ:SYM
39.3B USD
17%
-5%
-1%
US
Reddit Inc
NYSE:RDDT
38.7B USD
91%
14%
18%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
T Man Pharmaceutical PCL Competitors

Country Company Market Cap ROE ROA ROCE ROIC
TH
T Man Pharmaceutical PCL
SET:TMAN
4.2B THB
0%
0%
0%
0%
UK
Eight Capital Partners PLC
F:ECS
633.6T EUR N/A N/A N/A N/A
US
GE Vernova LLC
NYSE:GEV
157.3B USD
19%
3%
8%
2%
US
China Industrial Group Inc
OTC:CIND
121B USD
39%
24%
37%
34%
MY
Malton Bhd
KLSE:MALTON
218m MYR
1%
0%
5%
1%
NL
Nepi Rockcastle NV
JSE:NRP
87B Zac
12%
7%
7%
6%
US
Coupang Inc
F:788
45.4B EUR
9%
2%
9%
7%
US
CoreWeave Inc
NASDAQ:CRWV
46.7B USD
-42%
-6%
2%
2%
CH
Galderma Group AG
SIX:GALD
35.4B CHF
5%
3%
7%
5%
US
Symbotic Inc
NASDAQ:SYM
39.3B USD
-5%
-1%
-20%
-15%
US
Reddit Inc
NYSE:RDDT
38.7B USD
15%
14%
11%
57%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less